Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Impact of Sensory Electrical Stimulation on Sensation and Tremor

NCT: NCT06428526 · SUSPENDED

NCT IDNCT06428526
StatusSUSPENDED
Start Date2025-01-24
Completion2026-07-15
SponsorShirley Ryan AbilityLab (OTHER)
First posted
Last updated

Brief Summary

The purpose of this study is to understand the acute, short-term and long-term impact of transcutaneous and/or percutaneous electrical stimulation with afferent-specific electrical stimulation (asES) on proprioception and fine motor control in the upper extremity. For this purpose, the researchers will use transcutaneous and/or percutaneous asES, high-density electromyography (HD-EMG), arm kinematic measurements, and standardized clinical assessments. This study will be conducted in healthy able-bodied individuals and patients with essential tremor (ET).

Frequently Asked Questions

What is Impact of Sensory Electrical Stimulation on Sensation and Tremor?

Impact of Sensory Electrical Stimulation on Sensation and Tremor is a clinical trial registered under NCT06428526. Current status: SUSPENDED.

What is the status of NCT06428526?

The current status of NCT06428526 (Impact of Sensory Electrical Stimulation on Sensation and Tremor) is: SUSPENDED.

When did Impact of Sensory Electrical Stimulation on Sensation and Tremor start?

Impact of Sensory Electrical Stimulation on Sensation and Tremor started on 2025-01-24.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.